Zlotnikov Igor D, Ezhov Alexander A, Kudryashova Elena V
Faculty of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.
Faculty of Physics, Lomonosov Moscow State University, Leninskie Gory, 1/2, 119991 Moscow, Russia.
Int J Mol Sci. 2025 Jul 14;26(14):6749. doi: 10.3390/ijms26146749.
L-asparaginase (L-ASNase) remains a vital chemotherapeutic agent for acute lymphoblastic leukemia (ALL), primarily due to its mechanism of depleting circulating asparagine essential for leukemic cell proliferation. However, existing ASNases (including pegylated ones) face limitations including immunogenicity, rapid clearance, and off-target toxicities. Earlier, we have shown that the conjugation of L-ASNase with the polyamines and their copolymers results in significant enhancement of the antiproliferative activity due to accumulation in tumor cells. We suggested that this effect is probably mediated by polyamine transport system (PTS) receptors that are overexpressed in ALL cells. Here, we investigated the effect of competitive inhibitors of PTS receptors to the L-ASNase interaction with cancer cells (L5178Y, K562 and A549). L-ASNase from (RrA), (EwA), and (EcA) were conjugated with natural polyamines (spermine-spm, spermidine-spd, putrescine-put) and a synthetic branched polymer, polyethyleneimine 2 kDa (PEI2 ), using carbodiimide chemistry. Polyamine conjugation with L-ASNase significantly increased enzyme binding and cellular uptake, as quantified by fluorimetry and confocal microscopy. This increased cellular uptake translated into increased cytotoxicity of L-ASNase conjugates. The presence of competitive ligands to PTS receptors decreased the uptake of polyamine-conjugated enzymes-fatty acid derivatives of polyamines produced the strongest suppression. Simultaneously with this suppression, in some cases, competitive ligands to PTS significantly promoted the uptake of the native unconjugated enzymes, "equalizing" the cellular access for native vs conjugated ASNase. The screening for competing inhibitors of PTS receptor-mediated endocytosis revealed spermine and caproate/lipoate derivatives as the most potent inhibitors or antagonists, significantly reducing the cytostatic efficacy of polyamine-conjugated ASNases. The results obtained emphasize the complex, cell-type-dependent and inhibitor-specific nature of these interactions, which highlights the profound involvement of PTS in L-ASNase internalization and cytotoxic activity. These findings support the viability of polyamine conjugation as a strategy to enhance L-ASNase delivery and therapeutic efficacy by targeting the PTS.
L-天冬酰胺酶(L-ASNase)仍然是急性淋巴细胞白血病(ALL)的一种重要化疗药物,主要是因为其能够消耗白血病细胞增殖所必需的循环天冬酰胺。然而,现有的天冬酰胺酶(包括聚乙二醇化的天冬酰胺酶)存在免疫原性、快速清除和脱靶毒性等局限性。此前,我们已经表明,L-天冬酰胺酶与多胺及其共聚物的缀合会导致抗增殖活性显著增强,这是由于其在肿瘤细胞中的积累。我们认为这种效应可能是由ALL细胞中过表达的多胺转运系统(PTS)受体介导的。在此,我们研究了PTS受体竞争性抑制剂对L-天冬酰胺酶与癌细胞(L5178Y、K562和A549)相互作用的影响。使用碳二亚胺化学方法,将来自 (RrA)、 (EwA)和 (EcA)的L-天冬酰胺酶与天然多胺(精胺-spm、亚精胺-spd、腐胺-put)以及一种合成支链聚合物2 kDa聚乙烯亚胺(PEI2 )进行缀合。通过荧光测定法和共聚焦显微镜定量分析,多胺与L-天冬酰胺酶的缀合显著增加了酶的结合和细胞摄取。这种增加的细胞摄取转化为L-天冬酰胺酶缀合物细胞毒性的增加。PTS受体竞争性配体的存在降低了多胺缀合酶的摄取——多胺的脂肪酸衍生物产生了最强的抑制作用。在这种抑制的同时,在某些情况下,PTS的竞争性配体显著促进了天然未缀合酶的摄取,使天然和缀合的天冬酰胺酶在细胞内的摄取“趋于平衡”。对PTS受体介导的内吞作用竞争性抑制剂的筛选显示,精胺和己酸盐/硫辛酸酯衍生物是最有效的抑制剂或拮抗剂,它们显著降低了多胺缀合天冬酰胺酶的细胞生长抑制功效。所获得的结果强调了这些相互作用复杂、细胞类型依赖性和抑制剂特异性的性质,这突出了PTS在L-天冬酰胺酶内化和细胞毒性活性中的深刻参与。这些发现支持了多胺缀合作为一种通过靶向PTS来增强L-天冬酰胺酶递送和治疗效果的策略的可行性。